BILE DUCT OBSTRUCTION side effect
What is BILE DUCT OBSTRUCTION ?Drugs associated with BILE DUCT OBSTRUCTION
ACTOS BETASERON BEVACIZUMAB CARBOPLATIN CELEBREX CEREZYME CETUXIMAB CRESTOR ERLOTINIB FLUOROURACIL FORTEO GLEEVEC INFERGEN LAMISIL LAPATINIB MITOMYCIN PRAVACHOL PROGRAF REBIF REVLIMID RITONAVIR SANDIMMUNE SANDOSTATIN SIROLIMUS SORIATANE SYNTHROID TACROLIMUS THALIDOMIDE TIOTROPIUM ZYPREXABILE DUCT OBSTRUCTION : Thalidomide Side Effects Report #5657522-5
Health Professional from UNITED STATES reported THALIDOMIDE problem on Mar 07, 2008. Male patient, weighting 174.2 lb, was diagnosed with prostate cancer and was treated with THALIDOMIDE. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, disease progression, international normalised ratio increased, jaundice, . THALIDOMIDE dosage: 100MG ONCE A DAY PO. During the same period patient was treated with DOXIL. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Zyprexa Side Effects Report #5676908-6
ZYPREXA problem was reported by a Physician from UNITED STATES on Mar 10, 2008. Male patient was diagnosed with schizophrenia and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, . ZYPREXA dosage: 2.5 MG, EACH MORNING. During the same period patient was treated with KLONOPIN. Patient recovered.
BILE DUCT OBSTRUCTION : Tacrolimus Side Effects Report #5638767-7
Physician from AUSTRALIA reported TACROLIMUS problem on Feb 08, 2008. Female patient, child 9 years of age, was diagnosed with liver transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, chest pain, cytomegalovirus oesophagitis, haemolytic anaemia, lymphopenia, pyrexia, rash maculo-papular, renal failure, small intestinal obstruction, . TACROLIMUS dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE, AZATHIOPRINEECTION, GANCICLOVIR, PREDNISONE, COTRIM, VALACYCLOVIR. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Cerezyme Side Effects Report #5584895-4
CEREZYME problem was reported by a Physician from UNITED STATES on Dec 24, 2007. Male patient, 41 years of age, weighting 190.0 lb, was diagnosed with gaucher's disease and was treated with CEREZYME. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, . CEREZYME dosage: unknown. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Bevacizumab Side Effects Report #5595622-9
Health Professional from UNITED STATES reported BEVACIZUMAB problem on Jan 16, 2008. Male patient, 73 years of age, weighting 205.0 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, cholangitis, sepsis, . BEVACIZUMAB dosage: 930MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient was hospitalized and became disabled. Patient recovered.
BILE DUCT OBSTRUCTION : Tiotropium Side Effects Report #5599030-6
TIOTROPIUM problem was reported by a Consumer or non-health professional from on Jan 16, 2008. Female patient, 63 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with TIOTROPIUM. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, gastrointestinal pain, . TIOTROPIUM dosage: unknown. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Crestor Side Effects Report #5607469-5
Health Professional from CANADA reported CRESTOR problem on Jan 22, 2008. Female patient, 57 years of age, was diagnosed with hypercholesterolaemia and was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, hepatic enzyme increased, . CRESTOR dosage: unknown. During the same period patient was treated with RANITIDINE, BISOPROLOL, PHENYTOIN, RISPERIDONE, TYLENOL W. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Soriatane Side Effects Report #5614667-3
SORIATANE problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 23, 2008. Male patient, 62 years of age, weighting 260.0 lb, was diagnosed with psoriasis, blood cholesterol increased and was treated with SORIATANE. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, cholelithiasis, headache, rash macular, skin disorder, skin inflammation, . SORIATANE dosage: 25 MG; QD; PO. During the same period patient was treated with LIPITOR, LIDEX, PREVACID, VITAMIN CAP. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Carboplatin Side Effects Report #5535721-0
Consumer or non-health professional from UNITED STATES reported CARBOPLATIN problem on Dec 04, 2007. Female patient, weighting 128.3 lb, was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, . CARBOPLATIN dosage: 644 MG. During the same period patient was treated with TAXOL. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Rebif Side Effects Report #5543597-0
REBIF problem was reported by a Physician from UNITED STATES on Nov 28, 2007. Female patient, 64 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, metastases to liver, oedema peripheral, pancreatic carcinoma metastatic, . REBIF dosage: unknown. Patient was hospitalized. Patient died on 10/25/2007.
BILE DUCT OBSTRUCTION : Revlimid Side Effects Report #5553460-7
Physician from UNITED STATES reported REVLIMID problem on Dec 03, 2007. Female patient, 70 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, pneumonia, transient ischaemic attack, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Bevacizumab Side Effects Report #5562787-4
BEVACIZUMAB problem was reported by a Health Professional from UNITED STATES on Dec 12, 2007. Female patient, weighting 94.80 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, disease progression, gastrointestinal haemorrhage, neutropenia, white blood cell count increased, . BEVACIZUMAB dosage: 450MG Q2WKS IV. During the same period patient was treated with GEMCITABINE, DOCETAXEL. Patient recovered.
BILE DUCT OBSTRUCTION : Prograf Side Effects Report #5577649-6
Physician from UNITED STATES reported PROGRAF problem on Dec 18, 2007. Male patient, 40 years of age, was diagnosed with liver transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, cholangitis chronic, enterococcal infection, escherichia sepsis, impaired gastric emptying, post procedural complication, septic shock, . PROGRAF dosage: unknown. During the same period patient was treated with AZATHIOPRINE, PREDNISOLONE ACETATE, LAMIVUDINE, OMEPRAZOLE, INSULIN. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Fluorouracil Side Effects Report #5580503-7
FLUOROURACIL problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 31, 2007. Male patient, weighting 112.7 lb, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, condition aggravated, scan abdomen abnormal, . FLUOROURACIL dosage: 9296 MG. During the same period patient was treated with BEVACIZUMAB, LEUCOVORIN CALCIUM, ELOXATIN. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Revlimid Side Effects Report #5583590-5
Physician from UNITED STATES reported REVLIMID problem on Dec 26, 2007. Male patient, 70 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, hepatic failure, jaundice cholestatic, . REVLIMID dosage: 15 MG, DAILY, ORAL. During the same period patient was treated with DECADRON, COUMADIN, ALLOPURINOL, POTASSIUM. Patient was hospitalized. Patient died on 10/29/2007.
BILE DUCT OBSTRUCTION : Forteo Side Effects Report #5505373-4
FORTEO problem was reported by a Consumer or non-health professional from SPAIN on Oct 23, 2007. Female patient, 77 years of age, was diagnosed with osteoporosis, hypertension, pain and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, . FORTEO dosage: unknown. During the same period patient was treated with MICARDIS, GELOCATIL. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Rebif Side Effects Report #5507150-7
Consumer or non-health professional from UNITED STATES reported REBIF problem on Oct 23, 2007. Female patient, 48 years of age, weighting 300.0 lb, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, pancreatitis, pharyngeal disorder, pharyngeal injury, . REBIF dosage: unknown. During the same period patient was treated with COUMADIN, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Tiotropium Side Effects Report #5512076-9
TIOTROPIUM problem was reported by a Consumer or non-health professional from on Nov 05, 2007. Female patient, 63 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with TIOTROPIUM. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, gastrointestinal pain, . TIOTROPIUM dosage: unknown. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Revlimid Side Effects Report #5515210-X
Physician from UNITED STATES reported REVLIMID problem on Oct 29, 2007. Female patient, 70 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, gallbladder disorder, pneumonia, transient ischaemic attack, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Betaseron Side Effects Report #5520101-4
BETASERON problem was reported by a Consumer or non-health professional from CANADA on Nov 03, 2007. Female patient, 44 years of age, weighting 154.3 lb, was diagnosed with relapsing-remitting multiple sclerosis, hypothyroidism and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, cholecystectomy, jaundice, musculoskeletal stiffness, stent occlusion, thyroid neoplasm, . BETASERON dosage: unknown. During the same period patient was treated with CHOLESTYRAMINE, TAMOXIFEN CITRATE, TAMOXIFEN CITRATE, URSODIOL, CIPRO, FLAGYL, SYNTHROID. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Betaseron Side Effects Report #5524651-6
Consumer or non-health professional from CANADA reported BETASERON problem on Nov 20, 2007. Female patient, 44 years of age, weighting 154.3 lb, was diagnosed with relapsing-remitting multiple sclerosis, hypothyroidism and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, cholecystectomy, jaundice, musculoskeletal stiffness, stent occlusion, thyroid neoplasm, . BETASERON dosage: unknown. During the same period patient was treated with CHOLESTYRAMINE, TAMOXIFEN CITRATE, TAMOXIFEN CITRATE, URSODIOL, CIPRO, FLAGYL, SYNTHROID. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Bevacizumab Side Effects Report #5479452-4
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Sept 17, 2007. Male patient was diagnosed with adenocarcinoma pancreas and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, cholangitis, hypoxia, transaminases increased, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with ERLOTINIB, GEMCITABINE, ATENOL, COLACE, HUMULIN N, COMPAZINE, ZOFRAN, PROPAFENONE. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Erlotinib Side Effects Report #5481996-6
Health Professional from UNITED STATES reported ERLOTINIB problem on Sept 20, 2007. Male patient, 63 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, bile duct stenosis, blood glucose decreased, cholangitis, confusional state, disease progression, pneumonia aspiration, respiratory distress, . ERLOTINIB dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, COLACE, ZOFRAN, COMPAZINE, ATENOLOL, INSULIN NPH, PROPAFENONE. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Erlotinib Side Effects Report #5498435-1
ERLOTINIB problem was reported by a Health Professional from UNITED STATES on Oct 08, 2007. Male patient, 63 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, blood glucose decreased, cholangitis, confusional state, disease progression, malignant hepatobiliary neoplasm, pneumonia aspiration, prothrombin time prolonged, . ERLOTINIB dosage: 100MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, COLACE, ZOFRAN, COMPAZINE, ATENOL, INSULIN NPH, PROPAFENONE. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Revlimid Side Effects Report #5448366-8
Physician from UNITED STATES reported REVLIMID problem on Aug 27, 2007. Male patient, 60 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, . REVLIMID dosage: 25 MG, DAILY, ORAL. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Bevacizumab Side Effects Report #5463526-8
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Sept 17, 2007. Male patient was diagnosed with adenocarcinoma pancreas and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, cholangitis, hypoxia, transaminases increased, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with ERLOTINIB, GEMCITABINE, ATENOL, COLACE, HUMULIN N, COMPAZINE, ZOFRAN, PROPAFENONE. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Rebif Side Effects Report #5470195-X
Health Professional from UNITED STATES reported REBIF problem on Sept 11, 2007. Female patient, 48 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, cholelithiasis, fatigue, gastrointestinal disorder, injection site erythema, injection site pruritus, injection site swelling, multiple sclerosis relapse, post procedural complication, . REBIF dosage: unknown. During the same period patient was treated with CYMBALTA, AMBIEN CR. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Actos Side Effects Report #5470867-7
ACTOS problem was reported by a Consumer or non-health professional from GERMANY on Sept 12, 2007. Female patient, 75 years of age, was diagnosed with diabetes mellitus and was treated with ACTOS. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, bile duct stone, . ACTOS dosage: 45 MG (45 MG,1 IN 1 D). During the same period patient was treated with TOREM, METOPROLOL TARTRATE, LISINOPRIL, METFORMIN. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Cetuximab Side Effects Report #5419082-3
Consumer or non-health professional from UNITED STATES reported CETUXIMAB problem on Aug 17, 2007. Female patient was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, jaundice, malignant neoplasm progression, metastases to peritoneum, pancreatic carcinoma metastatic, . CETUXIMAB dosage: unknown. During the same period patient was treated with GEMCITABINE, OXALIPLATIN, AMITRIPTYLINE, MORPHINE, TYLENOL. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Pravachol Side Effects Report #5429811-0
PRAVACHOL problem was reported by a Consumer or non-health professional from AUSTRALIA on Aug 20, 2007. Male patient was diagnosed with myocardial infarction and was treated with PRAVACHOL. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, liver disorder, . PRAVACHOL dosage: unknown. During the same period patient was treated with TENORMIN, CARDIPRIM, ZYLOPRIM, FOSAMAX, PLAVIX. Patient recovered.
BILE DUCT OBSTRUCTION : Mitomycin Side Effects Report #5385512-9
Consumer or non-health professional from UNITED STATES reported MITOMYCIN problem on July 03, 2007. Female patient was diagnosed with adenocarcinoma pancreas and was treated with MITOMYCIN. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, . MITOMYCIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, DIPYRIDAMOLE, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Lapatinib Side Effects Report #5386553-8
LAPATINIB problem was reported by a Physician from UNITED STATES on July 06, 2007. Female patient, 39 years of age, weighting 130.1 lb, was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, . LAPATINIB dosage: 1250MG PER DAY. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient died on 04/27/2007.
BILE DUCT OBSTRUCTION : Lapatinib Side Effects Report #5395439-4
Physician from UNITED STATES reported LAPATINIB problem on July 18, 2007. Female patient, 39 years of age, weighting 130.1 lb, was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, disease progression, jaundice, . LAPATINIB dosage: 1250MG PER DAY. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient died on 04/27/2007.
BILE DUCT OBSTRUCTION : Mitomycin Side Effects Report #5385512-9
MITOMYCIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 03, 2007. Female patient was diagnosed with adenocarcinoma pancreas and was treated with MITOMYCIN. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, . MITOMYCIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, DIPYRIDAMOLE, LEUCOVORIN CALCIUM. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Lapatinib Side Effects Report #5386553-8
Physician from UNITED STATES reported LAPATINIB problem on July 06, 2007. Female patient, 39 years of age, weighting 130.1 lb, was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, . LAPATINIB dosage: 1250MG PER DAY. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient died on 04/27/2007.
BILE DUCT OBSTRUCTION : Lapatinib Side Effects Report #5395439-4
LAPATINIB problem was reported by a Physician from UNITED STATES on July 18, 2007. Female patient, 39 years of age, weighting 130.1 lb, was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: bile duct obstruction, disease progression, jaundice, . LAPATINIB dosage: 1250MG PER DAY. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient died on 04/27/2007.
BILE DUCT OBSTRUCTION : Celebrex Side Effects Report #5654110-1
Consumer or non-health professional from UNITED STATES reported CELEBREX problem on Feb 28, 2008. Female patient, weighting 140.3 lb, was diagnosed with fibromyalgia and was treated with CELEBREX. After drug was administered, patient experienced the following problems/side effects: anaemia, bile duct obstruction, eye swelling, gastric disorder, insomnia, large intestinal haemorrhage, swelling face, . CELEBREX dosage: unknown. During the same period patient was treated with LYRICA, OXYCONTIN. Patient recovered.
BILE DUCT OBSTRUCTION : Lapatinib Side Effects Report #5612590-1
LAPATINIB problem was reported by a Physician from UNITED STATES on Jan 29, 2008. Male patient, 80 years of age, weighting 123.2 lb, was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: abdominal pain, bile duct obstruction, chromaturia, dyspnoea, fatigue, hepatic enzyme increased, hepatic function abnormal, hyperbilirubinaemia, jaundice, . LAPATINIB dosage: 1500MG PER DAY. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Infergen Side Effects Report #5648169-5
Consumer or non-health professional from UNITED STATES reported INFERGEN problem on Feb 15, 2008. Male patient was diagnosed with hepatitis c and was treated with INFERGEN. After drug was administered, patient experienced the following problems/side effects: asthenia, bile duct obstruction, brain injury, cholangitis sclerosing, disorientation, gastrointestinal haemorrhage, transplant failure, weight decreased, white blood cell count decreased, . INFERGEN dosage: unknown. During the same period patient was treated with RIBAVIRIN, PANTOPRAZOLE, PROCRIT, VALSARTAN, OXYCODONE, ATIVAN. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Lapatinib Side Effects Report #5609160-8
LAPATINIB problem was reported by a Health Professional from UNITED STATES on Jan 30, 2008. Male patient, 80 years of age, weighting 123.0 lb, was diagnosed with pancreatic carcinoma and was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: abdominal pain, bile duct obstruction, chromaturia, dyspnoea, fatigue, hyperbilirubinaemia, jaundice, liver function test abnormal, malignant neoplasm progression, . LAPATINIB dosage: 1500MG DAILY PO. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Revlimid Side Effects Report #5476833-X
Physician from UNITED STATES reported REVLIMID problem on Sept 24, 2007. Male patient, 60 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, bile duct obstruction, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, hyperbilirubinaemia, . REVLIMID dosage: 25 MG, DAILY, ORAL. During the same period patient was treated with DEXAMETHASONE, ERYTHROPOIETIN, ZOMETA. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Ritonavir Side Effects Report #5481875-4
RITONAVIR problem was reported by a Consumer or non-health professional from SWITZERLAND on Oct 01, 2007. Male patient, weighting 130.3 lb, was diagnosed with hiv infection and was treated with RITONAVIR. After drug was administered, patient experienced the following problems/side effects: ascites, bile duct obstruction, bladder pain, cytomegalovirus antibody positive, deafness unilateral, ear discomfort, gallbladder disorder, haemangioma, . RITONAVIR dosage: unknown. During the same period patient was treated with DIDANOSINE, TENOFOVIR. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Cetuximab Side Effects Report #5416831-5
Consumer or non-health professional from UNITED STATES reported CETUXIMAB problem on Aug 15, 2007. Male patient was diagnosed with pancreatic carcinoma and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: bacteraemia, bile duct obstruction, cholangitis, medical device complication, . CETUXIMAB dosage: 736MG IV. During the same period patient was treated with GEMCITABINE, OXALIPLATIN, COUMADIN, PROTONIX, COLACE, PERCOCET, OXYCODONE. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Lamisil Side Effects Report #5379748-0
LAMISIL problem was reported by a Consumer or non-health professional from UNITED STATES on June 28, 2007. Male patient, 58 years of age, was diagnosed with fungal infection, blood cholesterol, hypertension, gastrooesophageal reflux disease and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: abdominal pain, bile duct obstruction, biliary drainage, condition aggravated, intestinal functional disorder, jaundice, liver disorder, pancreatic disorder, . LAMISIL dosage: 250 MG, BID. During the same period patient was treated with BENICAR, NORVASC, PROBENECID, ZETIA, PREVACID. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Sirolimus Side Effects Report #5387227-X
Physician from UNITED STATES reported SIROLIMUS problem on July 06, 2007. Male patient was diagnosed with prophylaxis against transplant rejection and was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, bile duct obstruction, cholangitis, clostridium difficile colitis, cough, dyspnoea, liver transplant rejection, thrombosis, upper respiratory tract infection, . SIROLIMUS dosage: unknown. During the same period patient was treated with PREDNISONE. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Lamisil Side Effects Report #5379748-0
LAMISIL problem was reported by a Consumer or non-health professional from UNITED STATES on June 28, 2007. Male patient, 58 years of age, was diagnosed with fungal infection, blood cholesterol, hypertension, gastrooesophageal reflux disease and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: abdominal pain, bile duct obstruction, biliary drainage, condition aggravated, intestinal functional disorder, jaundice, liver disorder, pancreatic disorder, . LAMISIL dosage: 250 MG, BID. During the same period patient was treated with BENICAR, NORVASC, PROBENECID, ZETIA, PREVACID. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Sirolimus Side Effects Report #5387227-X
Physician from UNITED STATES reported SIROLIMUS problem on July 06, 2007. Male patient was diagnosed with prophylaxis against transplant rejection and was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, bile duct obstruction, cholangitis, clostridium difficile colitis, cough, dyspnoea, liver transplant rejection, thrombosis, upper respiratory tract infection, . SIROLIMUS dosage: unknown. During the same period patient was treated with PREDNISONE. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Gleevec Side Effects Report #5680193-9
GLEEVEC problem was reported by a Pharmacist from UNITED STATES on Mar 17, 2008. Female patient, 65 years of age, weighting 181.0 lb, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bile duct obstruction, blood alkaline phosphatase increased, chromaturia, computerised tomogram abnormal, gastritis, jaundice, pancreatic enlargement, . GLEEVEC dosage: 400 MG, QD. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Sandostatin Side Effects Report #5556098-0
Consumer or non-health professional from CANADA reported SANDOSTATIN LAR problem on Dec 03, 2007. Male patient was diagnosed with carcinoid tumour and was treated with SANDOSTATIN LAR. After drug was administered, patient experienced the following problems/side effects: anxiety, asthenia, bile duct obstruction, blood product transfusion, clotting factor transfusion, costovertebral angle tenderness, diarrhoea, fatigue, hepatic embolisation, . SANDOSTATIN LAR dosage: 30MG EVERY 4 WEEKS. During the same period patient was treated with SANDOSTATIN LAR, INSULIN. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Synthroid Side Effects Report #5523108-6
SYNTHROID problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 14, 2007. Female patient, 93 years of age, weighting 90.08 lb, was diagnosed with hypothyroidism, hypertension and was treated with SYNTHROID. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, abdominal pain upper, bile duct obstruction, disorientation, vomiting, . SYNTHROID dosage: unknown. Patient was hospitalized. Patient recovered.
BILE DUCT OBSTRUCTION : Lamisil Side Effects Report #5486300-5
Physician from UNITED STATES reported LAMISIL problem on Oct 10, 2007. Male patient, 58 years of age, was diagnosed with fungal infection, blood cholesterol, hypertension, gastrooesophageal reflux disease and was treated with LAMISIL. After drug was administered, patient experienced the following problems/side effects: abdominal pain, alcoholic pancreatitis, bile duct obstruction, bile duct stenosis, biliary drainage, hepatobiliary disease, intestinal functional disorder, jaundice, liver disorder, . LAMISIL dosage: 250 MG, BID. During the same period patient was treated with BENICAR, NORVASC, PROBENECID, ZETIA, PREVACID. Patient was hospitalized. Patient recovered.